Home
About us
Ventures
Team
Newsroom
Contact
Investor Relations
Deutsch
Home
About us
Ventures
Team
Newsroom
Contact
Investor Relations
Deutsch
Investor Relations
NEWSROOM
Overview of the latest Company News, Press Releases and Ad-hoc announcements
Featured
Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval
The Annual General Meeting of SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) has confirmed the strategic growth course of the European industrial hemp and cannabis company group with an overwhelming majority.
Read more
Recent
Articles Corporate News
More Corporate News
Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval
SYNBIOTIC Annual General Meeting on 20.09.2024: Increasing sales drive growth
SYNBIOTIC and CEO Daniel Kruse on roadshow
Recent
Press Reviews
More Press Reviews
1,6 Millionen Euro für Hanf Farm: Bundesministerium für Wirtschaft und Klimaschutz fördert Bio-Ökonomie-Projekt
SynBiotic: neue Pflichtwandelanleihe in petto
Welche ökonomischen Chancen das neue Cannabis-Gesetz bietet
Recent
Ad-hoc Releases
More Ad-hoc Releases
SynBiotic SE: Begebung einer Wandelanleihe von bis zu EUR 300.000,00 unter Ausschluss des Bezugsrechts beschlossen.
SynBiotic SE erwartet deutliches Umsatzwachstum für das Geschäftsjahr 2024
SynBiotic SE schließt Einbringungsvertrag über den Erwerb aller Anteile an der WEECO Pharma GmbH, Hildesheim ab